Major histocompatibility complex (MHC) tetramer technology: an evaluation.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 12408217)

Published in Biol Res Nurs on October 01, 2002

Authors

Carolyn M Constantin1, Elizabeth E Bonney, John D Altman, Ora L Strickland

Author Affiliations

1: Nell Hodgson Woodruff School of Nursing at Emory University, Atlanta, GA 30322-4207, USA. cconsta@learnlink.emory.edu

Articles by these authors

Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06

Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol (2006) 6.00

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity (2008) 5.22

Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med (2002) 5.16

Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol (2005) 2.87

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood (2009) 2.50

Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol (2002) 2.50

A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J Immunol Methods (2006) 2.36

Retracted Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection. Nature (2008) 2.22

Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med (2002) 2.20

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol (2003) 2.14

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J Virol (2002) 2.13

In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol (2002) 1.70

Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. J Virol (2002) 1.67

The experiences of midlife women with migraines. J Nurs Scholarsh (2006) 1.64

Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J Immunol (2003) 1.49

A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol (2013) 1.49

IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J Immunol (2008) 1.49

Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. J Clin Invest (2004) 1.48

Platelets support a protective immune response to LCMV by preventing splenic necrosis. Blood (2012) 1.46

Memory CD8+ T cells require CD28 costimulation. J Immunol (2007) 1.45

Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. J Virol (2002) 1.44

IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood (2002) 1.43

CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med (2011) 1.43

Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96. J Immunol (2011) 1.42

Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach. Cytometry A (2008) 1.40

Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. Virology (2005) 1.38

Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol (2004) 1.36

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines. J Virol (2002) 1.32

Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis. Nat Rev Immunol (2011) 1.32

Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J Immunol (2003) 1.22

Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression. J Immunol (2009) 1.19

Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J Virol (2009) 1.19

New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation. J Immunol (2009) 1.18

CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med (2013) 1.16

A robust method for production of MHC tetramers with small molecule fluorophores. J Immunol Methods (2006) 1.15

HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J Immunol (2004) 1.13

Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am J Trop Med Hyg (2005) 1.13

Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgrad Med (2009) 1.07

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Vaccine (2002) 1.06

Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays. J Immunol Methods (2003) 1.05

Normal establishment of virus-specific memory CD8 T cell pool following primary infection during pregnancy. J Immunol (2007) 1.03

HIV escape: there and back again. Nat Med (2004) 1.03

Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. J Immunol (2008) 1.02

A transgenic mouse model genetically tags all activated CD8 T cells. J Immunol (2003) 1.00

Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol (2002) 0.99

Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms. Cytometry A (2008) 0.94

Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system. Proc Natl Acad Sci U S A (2011) 0.94

Using factor analysis for validity assessment: practical considerations. J Nurs Meas (2003) 0.91

Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells. Blood (2006) 0.91

Cutting Edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J Immunol (2013) 0.91

Parental Human Papillomavirus Vaccine Survey (PHPVS): nurse-led instrument development and psychometric testing for use in research and primary care screening. J Nurs Meas (2013) 0.90

Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects. J Virol (2007) 0.89

Challenges and strategies of dyad research: cardiovascular examples. Appl Nurs Res (2009) 0.87

Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques. J Virol (2012) 0.87

Impact of unreliability of measurements on statistical conclusion validity. J Nurs Meas (2005) 0.84

Rural African American parents' knowledge and decisions about human papillomavirus vaccination. J Nurs Scholarsh (2012) 0.84

Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge. J Gen Virol (2002) 0.84

CD8 T cell memory recall is enhanced by novel direct interactions with CD4 T cells enabled by MHC class II transferred from APCs. PLoS One (2013) 0.83

CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells. J Immunol (2002) 0.83

Symptom clusters and health-related quality of life in people with chronic stable angina. J Adv Nurs (2011) 0.81

Cultural considerations and issues in measurement. J Nurs Meas (2004) 0.79

Genetic predictors of coronary heart disease risk factors in premenopausal African-American women. Ethn Dis (2005) 0.79

Measurement implications when developing and implementing interventions. J Nurs Meas (2005) 0.78

A guide to developing a culturally competent organization. J Transcult Nurs (2011) 0.78

Red blood cell transfusion-related necrotizing enterocolitis in very-low-birthweight infants: a near-infrared spectroscopy investigation. Transfusion (2013) 0.78

Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. Apoptosis (2007) 0.77

Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer. Cancer Nurs (2015) 0.76

Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cells. J Immunol Methods (2011) 0.75

Bacterial superantigen exposure after resolution of influenza virus infection perturbs the virus-specific memory CD8(+)-T-cell repertoire. J Virol (2002) 0.75

Online Data Collection in Women's Health Research: A Study of Perimenopausal Women with Migraines. NWSA J (2004) 0.75

Smallpox: a disease of the past? Consideration for midwives. J Midwifery Womens Health (2003) 0.75

Factors that can affect the accuracy and precision of physiological measurements. J Nurs Meas (2004) 0.75

Assessing data adequacy for clinical research: reliability and validity of a surgical database. J Nurs Meas (2002) 0.75

Using proxy respondents. J Nurs Meas (2005) 0.75

Patient outcomes and measures: special considerations. J Nurs Meas (2003) 0.75

Special considerations when conducting measurements with children. J Nurs Meas (2005) 0.75

Ensuring the credibility of physiological measurements: assessing error variability. J Nurs Meas (2004) 0.75

In search of reliability and validity evidence for an existing instrument. J Nurs Meas (2006) 0.75

Subdimensions and subscales in measurement and instrument development. J Nurs Meas (2002) 0.75

Transfusion-related necrotizing enterocolitis: a conceptual framework. Adv Neonatal Care (2013) 0.75

The importance of reporting sample characteristics in measurement studies. J Nurs Meas (2002) 0.75

Mothers, Fathers, Sons, and Human Papillomavirus Immunization Practices. Fam Community Health (2017) 0.75

Smallpox: an update for nurses. Biol Res Nurs (2003) 0.75